Atezolizumab and Bevacizumab with Transarterial Chemoembolization in Hepatocellular Carcinoma: The DEMAND Trial ProtocolNajib Ben Khaled, Enrico N. De Toni, Jens Ricke et al.|Future Oncology|2022Cited by 35